Halo Collective Inc. Stock price

Equities

HCANF

CA40638K7050

Healthcare Facilities & Services

Delayed OTC Markets 09:42:36 2024-01-02 am EST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Halo Collective Inc. -.--% -.--%
Sales 2021 36.18M Sales 2022 24.54M Capitalization 1.33M
Net income 2021 -94M Net income 2022 -83M EV / Sales 2021 1.54 x
Net Debt 2021 23.89M Net Debt 2022 16.65M EV / Sales 2022 0.73 x
P/E ratio 2021
-0.24 x
P/E ratio 2022
-
Employees 114
Yield 2021 *
-
Yield 2022
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Halo Collective Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Halo Collective Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Halo Collective Inc. Announces Change to Board of Directors CI
Transcript : Halo Collective Inc. - Shareholder/Analyst Call
Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations CI
Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors CI
Halo Collective Inc. Announces Launch of New Premium Cannabis Strains CI
Halo Collective Inc. Reports Highest Selling Quarter for Budega Retail Locations and Plans to Continue Expansion CI
Halo Collective Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Halo Collective Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Halo Collective Inc. Appoints Katie Field as Chairman of the Board CI
Halo Collective Receives All Regulatory Approvals for Its Third Budega Dispensary in Hollywood, Halo's First Superstore CI
Halo Collective Inc. Receives All Regulatory Approvals for its Third Budega™ Dispensary in Hollywood CI
Halo Collective Inc. (OTCPK:HCAN.F) cancelled the acquisition of Phytocann Holdings SA. CI
Halo Collective Inc. announced that it has received $6 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance and other investors CI
More news

Latest transcript on Halo Collective Inc.

1 year
0.00
Extreme 0
0.02
3 years
0.00
Extreme 0
1 100.00
5 years
0.00
Extreme 0
6 694.00
10 years
0.00
Extreme 0
6 800.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 19-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 55 22-03-01
Director/Board Member 29 22-03-01
Chief Executive Officer 41 19-03-31
More insiders
Halo Collective Inc. is a Canada-based vertically integrated cannabis company. The Company is engaged in cultivating, extracting, manufacturing, and distribution of quality cannabis flower, pre-rolls, vape carts, edibles, and concentrates. It offers products under a portfolio of brands, including Hush, Winberry Farms and Exhale, as well as under its retail brand Budega. It also sells its products under license agreement with Papa's Herb, DNA Genetics, and FlowerShop. It owns approximately 55,000 square feet indoor cannabis cultivation, processing, and wholesaling facility in Portland, Oregon. It is also focused on health and wellness categories, including cannabidiol (CBD) and functional supplements such as nootropic nutraceuticals and non-psychotropic mushrooms. It has product offerings in the form of beverages (H2C Beverages), dissolvable strips, capsules (Hushrooms), and topical supplements (Hatshe). It operates in the United States, Canada, Southern Africa and the United Kingdom.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Halo Collective Inc. - OTC Markets